Syros Pharmaceuticals, Inc. logo

Syros Pharmaceuticals, Inc.

NASDAQ:SYRS

Overview | Financials
Company Name Syros Pharmaceuticals, Inc.
Symbol SYRS
Currency USD
Price 0.209
Market Cap 5,607,993
Dividend Yield 0%
52-week-range 0.183 - 8.17
Industry Biotechnology
Sector Healthcare
CEO Dr. Nancy A. Simonian M.D.
Website https://www.syros.com

An error occurred while fetching data.

About Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset

Related Stocks

Catalyst Biosciences, Inc. logo

Catalyst Biosciences, Inc.

CBIO

0.511 USD

Corvus Pharmaceuticals, Inc. logo

Corvus Pharmaceuticals, Inc.

CRVS

5.21 USD

Venus Concept Inc. logo

Venus Concept Inc.

VERO

0.356 USD

Accelerate Diagnostics, Inc. logo

Accelerate Diagnostics, Inc.

AXDX

1.1 USD

MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc.

INKT

0.575 USD

ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V.

PRQR

2.79 USD

Financials

Numbers are in millions USD

Numbers are in millions USD